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Alzheimer Disease (AD) is one of the most famous neurodegenerative disor-
ders, and the neurofibrillary tangles serve as a hallmark of AD. They are
composed of paired helical filaments of hyperphosphorylated Tau proteins,
which are the microtubule-associated protein [1]. In order to understand the
functions of a protein, we must determine its structures. But Tau protein’s
structure hasn’t been identified because it is famous for being one of the intrin-
sically disordered proteins (IDP), which lack stable tertiary structures or sec-
ondary structures [2].
Here we observed Tau protein’s fluctuations with the Diffracted X-ray tracking
(DXT).
This method is able to monitor the tilting and twisting motions of single protein
molecules with nanometer resolution.
In this method, gold nanocrystals are attached on target protein molecules to
probe their intramolecular motions, and these proteins are irradiated with syn-
chrotron X-ray to get time displacements of Laue diffraction patterns from a
gold nanocrystal. As a synchrotron X-ray beamline, we used KEK NW-14A
and SPring-8 BL40XU in Japan.
In our experiment, in order to reveal the relation between an aggregation pro-
cess and hyperphosphorylated Tau proteins, we phosphorylated wild-type and
mutated recombinant Tau proteins with GSK-3b. Threonine and serine sites of
these mutated Tau proteins were converted into Alanine in order not to be phos-
phorylated. And we found tau protein molecules were fluctuating between 0.3-1
nm in aqueous solution when a shutter speed was 36 ms/frame. More impor-
tantly, their fluctuations decreased after phosphorylated by GSK-3b. Finally,
we specified the phosphorylation sites that affect structural fluctuations of
Tau proteins.
[1] A. Cavallini et al., J. Biol. Chem. 288, 23331-23347, (2013).
[2] V. Uversky et al., Annu. Rev. Biophys. 37, 215-246, (2008).
310-Pos Board B90
Simulation of the Distribution of Disordered Tau Proteins Around Its
Amyloid Fibrils Core
Liang Xu1, Martin Margittai2, Ruth Nussinov3, Buyong Ma3.
1School of Chemistry, Dalian University of Technology, Dalian, China,
2Department of Chemistry & Biochemistry, University of Denver, Dever,
CO, USA, 3Leidos Biomedical, NCI-Frederick, NIH, Frederick, MD, USA.
Tau is an intrinsically disordered protein (IDP) implicated in Alzheimer’s dis-
ease. Tau protein has 240-aa-long N-terminal domain, 125 aa micortubules
binding repeat domain, and 72 aa c-terminal domain. The tau fibril core is
formed by the repeat domain, and both N- and C-terminal domains remain
disordered in tau amyloid. There are experimental indications that these disor-
derd segments form fuzzy coat that resembles a two-layered polyelectrolyte
brush around tau fibril core. Previously, we have shown that tau fibrils formed
by the repeat domain K18 protein have polymorphic amyloid state. In this
work, using both all atom and coarse-grained Martini models, we simulated
the full length tau amyloid structure to investigate the distribution of disordered
tau proteins around its amyloid fibrils core. Our results provide insights into the
organization of full length tau fibrils.
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Tau is a microtubule associated protein that normally functions as a monomer
in league with the microtubule cytoskeleton. However, in Alzheimer’s disease
(AD), tau aggregates to form filamentous inclusions in cell bodies (neurofibril-
lary tangles, NFT) and cell processes (dystrophic neurites and neuropil
threads). The appearance of tau-bearing lesions correlates with neurodegener-
ation and cognitive decline, consistent with a connection between tau aggrega-tion and disease progression. Indeed, in biological models, tau aggregates are
toxic, with potency inversely proportional to aggregate size. However, the rela-
tionship between these species and the aggregation pathway is unknown.
Here we investigate the aggregation mechanism of tau protein in vitro in an
effort to identify interactions that manifest size dependence. The fits of a math-
ematical model describing simple nucleation-elongation polymerization to
aggregation time-series, consistently overestimated filament growth rate while
underestimating filament length distribution, indicating the presence of a sec-
ondary process in the pathway. On the basis of filament mixing and shearing ex-
periments, we identified end-to-end annealing as a novel secondary interaction
of nascent tau filaments.With the addition of an end-to-end annealing term to the
mathematical model in equilibrium with filament fragmentation, we found
improved fits for both time series and filament length distributions. In addition
to quantifying the intrinsic rate constants for annealing and fragmentation, the
model provided evidence for their dependence on filament length. The results
indicate that filament ends are active, and that their propensity to engage in ho-
motypic interactions is length dependent. We propose that heterotypic interac-
tions at filament ends are candidate mediators of toxicity in biological models.
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Neural amyloid deposits of microtubule-associated protein tau are implicated
in a number of neurodegenerative disorders, notably Alzheimer’s disease
(AD) and chronic traumatic encephalopathy (CTE). Fibrillization of tau,
and of amyloid-forming proteins in general, appears to involve nucleation-
dependent polymerization wherein small concentrations of ‘‘nuclei’’ form
initially, followed by the rapid, highly favorable addition of further monomer
to nuclei/fibril ends. Secondary nucleation, the formation of nuclei from
fibrillar material, is a particularly important determinant of amyloid formation
kinetics. When the reaction is monitored, this type of behavior results in highly
cooperative, sigmoidal fibrillization curves. A number of small molecules
derived from natural products have been shown to inhibit tau amyloid forma-
tion, but our understanding of their mechanistic effects is largely empirical.
A thorough investigation of the kinetic and structural effects of these com-
pounds could aid in the rational design of more potent, specific inhibitors.
Toward this end, we are utilizing a combination of fluorescence spectroscopy ,
mathematical modeling and numerical simulation to evaluate the heparin-
induced fibrillization of a fragment of tau, K18. This strategy enables us to
examine entire distributions of model parameter values that describe the data
with comparable accuracy, as opposed to the conventional approach of identi-
fying a single ‘‘best-fit’’ set of parameters. Both for experimental K18 fibrilli-
zation timecourses and for simulated sets of test data, the parameter distribution
approach appears to better reflect the true experimental uncertainties involved
in studies of amyloid formation than conventional least-squares fitting. These
parameter distributions are sensitive to relatively small changes in the underly-
ing kinetic rates, and we discuss how they can be used to assign detailed effects
to known small molecule inhibitors of tau amyloid formation in an effort to
generate more detailed models for their mechanisms of action.
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Tau proteins regulate the dynamics, stability and transport properties of cyto-
skeletal scaffolding microtubules. Functional tau monomer has been classified
as an intrinsically disordered protein. However, the degree of foldedness of the
protein and intrinsic capability of the protein to gain rigidity is not well under-
stood yet. We employed fluorescence, circular dichroism (CD), and Fourier
transform infrared (FTIR) spectroscopic techniques to analysis the foldedness
of the hTau24 isoform.
Fluorescence data with bis-ANS reveals that in acidic buffer (pH 3.3), the pro-
tein contains predominantly a molten globular structure, while the rigidity de-
grees partially collapse to a pre molten globular state in neutral and alkaline
buffers. Exploiting the tyrosine fluorescence at similar solvent conditions sug-
gests a three-dimensional structured domain(s) exists in soluble tau. Under
modest solvent changes, the soluble protein can adopt higher b-turn content,
and extended/b-sheet structures compared to the dominant disordered structure
of soluble tau in neutral buffer. Our CD data did not reveal the presence of
extended helix polyproline II structure.
In conclusion, due to the flexibility and potential ability of soluble tau to gain
or lose rigidity, microtubule-binding interactions that occur through spe-
cific folding is certainly a strong possibility. Furthermore, regardless of the
